共 50 条
- [31] UTILIZATION AND EXPENDITURES FOR NON-ALCOHOLIC STEATOHEPATITIS/NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS WITH ADVANCE FIBROSIS AND COMPENSATED CIRRHOSIS: RESULTS OF A REAL-WORLD ANALYSIS AMONG US PATIENTSGASTROENTEROLOGY, 2018, 154 (06) : S1110 - S1110Wong, Robert J.Fulcher, NicoleKent, ShiaGordon, Stuart C.
- [32] Diagnostic Performance of APRI, FIB-4, and NFS in Detecting Advanced Fibrosis Compared to Transient Elastography in Patients With Non-Alcoholic Fatty Liver Disease: Data From NHANESAMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S564 - S564Ramrakhiani, HannahHuang, Edward S.Liang, Su-YingShetler, Katerina
- [33] Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography,body mass index,and Fib-4 indexWorld Journal of Gastroenterology, 2023, (23) : 3703 - 3714Kei FunadaYumi KusanoYoshinori GyotokuRyosaku ShirahashiToshikuni SudaMasaya Tamano
- [34] Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 indexWORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (23) : 3703 - 3714Funada, KeiKusano, YumiGyotoku, YoshinoriShirahashi, RyosakuSuda, ToshikuniTamano, Masaya
- [35] Primary care sequential use of FIB-4 and the enhanced liver fibrosis test to stratify patients with non-alcoholic fatty liver disease increases cirrhosis detection and reduces referrals of patients with mild disease-2 year study analysisJOURNAL OF HEPATOLOGY, 2017, 66 (01) : S68 - S68Srivastava, A.Gailer, R.Demma, S.Warner, A.Suri, D.Morgan, S.Sennett, K.Thorburn, D.Parkes, J.Tsochatzis, E.Rosenberg, W.
- [36] Accuracy of FIB-4 to Detect Elevated Liver Stiffness Measurements in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Referral CentersINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)Vigano, MauroPugliese, NicolaCerini, FedericaTurati, FedericaCimino, VincenzoRidolfo, SofiaRocchetto, SimoneFoglio, FrancescaTerrin, MariaLa Vecchia, CarloRumi, Maria GraziaAghemo, Alessio
- [37] IMPORTANCE AND UTILITY OF FIBROSCAN IN ASSOCIATION WITH FIB-4, FOR ASSESSMENT OF LIVER FIBROSIS IN T2DM FEMALE PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASEDIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A190 - A190Padhye, D.Tanna, S.James, A.Nair, N.Shah, M.Kovil, R.
- [38] CLINICAL CHARACTERISTICS AND FIB-4 RISK STRATIFICATION OF PRIMARY CARE PATIENTS WITH OBESITY, DIABETES, OR BOTH: REAL-WORLD IMPLICATIONS FOR ADOPTING A FIB-4 REFERRAL ALGORITHM TO DETECT METABOLIC DYSFUNCTION-ASSOCIATION STEATOTIC LIVER DISEASE (MASLD) WITH ADVANCED FIBROSISHEPATOLOGY, 2024, 80 : S868 - S869Chu, JanetKhalili, MandanaGoldman, MaxHameed, BilalHa, NghiemFox, Rena
- [39] Use of the fibrosis-4 score to estimate fibrosis stage for patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in retrospective real-world datasets: a targeted literature review and feasibility assessmentJOURNAL OF HEPATOLOGY, 2020, 73 : S439 - S439Qiu, YingWang, YuexiByrne, ClareTang, JacksonMyers, Joel
- [40] SIGNIFICANT KNOWLEDGE GAP ABOUT NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN REAL-WORLD PRACTICES: A GLOBAL SURVEY OF HEPATOLOGISTS, GASTROENTEROLOGISTS, ENDOCRINOLOGISTS AND PRIMARY CARE PHYSICIANSHEPATOLOGY, 2020, 72 : 410A - 411AYounossi, Zobair M.Takahashi, HirokazuEguchi, YuichiroYilmaz, YusufEl Kassas, MohamedZheng, Ming-HuaFang, Jian-GaoWong, Vincent Wai-SunAlswat, Khalid AidaChan, Wah Kheong, Sr.Mendez-Sanchez, NahumBurra, PatriziaBugianesi, ElisabettaDuseja, AjayFerret, Maria Asuncion ButiDiago, MoisesRomero-Gomez, ManuelGeorge, JacobPapatheodoridis, GeorgeHamid, Saeed S.Castera, LaurentArrese, MarcoKugelmas, MarceloOng, JanusZiayee, MariamYounossi, LssahRacila, AndreiHenry, LindaStepanova, Maria